Thomas B. Julian

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy”.

Omitting Regional Nodal Irradiation after Response to Neoadjuvant Chemotherapy

New England Journal of Medicine(2025)10.1056/nejmoa2414859

N/A

1.2DataRank · unranked

93 citations

Hanna Bandos, Julia White, Thomas B. Julian, Atif J. Khan, Simona F. Shaitelman +23 more

Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology)

Breast Cancer Research and Treatment(2022)10.1007/s10549-021-06417-y

N/A

0.593DataRank · unranked

10 citations

Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher +13 more

Racial disparity in distant recurrence‐free survival in patients with localized breast cancer: A pooled analysis of National Surgical Adjuvant Breast and Bowel Project trials

Cancer(2022)10.1002/cncr.34241

N/A

0DataRank · unranked

25 citations

Jessica Pastoriza, Jiyue Qin, Juan Lin, George S. Karagiannis, John S. Condeelis +9 more

Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.508

N/A

0DataRank · unranked

9 citations

Stewart Anderson, Kalliopi P. Siziopikou, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch +15 more

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps613

N/A

0DataRank · unranked

31 citations

Stewart Anderson, Eleanor Harris, Eleftherios P. Mamounas, Daniel G. Stover, Patricia A. Ganz +11 more

NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps623

N/A

0DataRank · unranked

6 citations

Reena S. Cecchini, Eleanor Harris, Eleftherios P. Mamounas, Daniel G. Stover, Patricia A. Ganz +12 more

Definitive Results of a Phase III Adjuvant Trial Comparing Six Cycles of FEC-100 to Four Cycles of AC in Women with Operable Node-negative Breast Cancer: The NSABP B-36 Trial (NRG Oncology)

Research Square(2021)10.21203/rs.3.rs-841103/v1

N/A

0DataRank · unranked

3 citations

Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher +13 more